- The Common Equity Tier 1 (CET 1, formerly: Core Tier 1) capital ratio, calculated on the basis of CRR/CRD 4 (phase-in rate of 20 %), was 15.2 % as of December 31, 2014, compared with 12.8 % at year-end 2013 based on Basel 2.5. Our pro forma CRR/CRD 4 (phase-in rate of 0 %) CET 1 capital ratio was 14.6 % at year-end 2013.
- CET 1 capital according to CRR/CRD 4 increased by € 21.6 billion to € 60.1 billion as of December 31, 2014, compared with € 38.5 billion CET 1 capital at year-end 2013 according to Basel 2.5. The framework change has led to a positive first-day application effect of € 10.4 billion due to the applicable phase-in rate of 20 % for 2014, mainly driven by the treatment of intangible assets of € 9.2 billion. During the transitional period, CRR/CRD 4 allows subtraction of certain CET 1 deductions from Additional Tier 1 capital instead of CET 1 capital, to ease the transition for banks to the “fully-loaded” rules. The remaining € 11.1 billion increase was mainly driven by our capital increase from authorized capital against cash contributions with gross proceeds of € 8.5 billion.
- Additional Tier 1 (AT1) capital according to CRR/CRD 4 decreased by € 8.4 billion to € 3.8 billion as of December 31, 2014, compared with € 12.2 billion AT1 capital at year-end according to Basel 2.5. We had a negative first-day effect from application of CRR/CRD 4 rules of € 12.0 billion, largely reflecting deductions from intangible assets of € 9.2 billion as well as the derecognition of AT1 instruments of € 2.2 billion that no longer qualify as AT1 capital. The first-day effect was partly offset by the issuance of CRR/CRD 4 compliant AT1 Notes of € 4.6 billion.
- Tier 2 capital according to CRR/CRD 4 decreased by € 0.4 billion to € 4.4 billion as of December 31, 2014, compared with € 4.7 billion Tier 2 capital at year-end according to Basel 2.5, mainly due to redemptions and amortization adjustments that were partly offset by deduction reliefs from securitizations and significant investments in financial and insurance entities.
- RWA according to CRR/CRD 4 increased by € 96 billion to € 397 billion as of December 31, 2014, compared with € 300 billion at year-end 2013 based on Basel 2.5. Our pro forma CRR/CRD 4 RWA were € 355 billion at year-end 2013. The RWA increase is mainly reflecting the impact from the CRR/CRD 4 framework including RWA for CVA, higher operational risk RWA and credit risk RWA including the impact from foreign exchange movements. That was partly offset by de-risking and asset sales.
Overview of Regulatory Capital, RWA and Capital Ratios according to CRR/CRD 4 and Basel 2.5 (audited) |
|||
|
Dec 31, 2014 |
Dec 31, 2013 |
|
in € m. |
CRR/CRD 4 |
CRR/CRD 4 |
Basel 2.5 |
Common Equity Tier 1 capital before regulatory adjustments |
65,750 |
66,175 |
53,558 |
Total regulatory adjustments to Common Equity Tier 1 (CET 1) capital |
(19,674) |
(6,072) |
(15,024) |
Common Equity Tier 1 (CET 1) capital |
46,076 |
60,103 |
38,534 |
Additional Tier 1 (AT1) capital before regulatory adjustments |
4,676 |
14,696 |
12,701 |
Total regulatory adjustments to Additional Tier 1 (AT1) capital |
(57) |
(10,902) |
(519) |
Additional Tier 1 (AT1) capital |
4,619 |
3,794 |
12,182 |
Tier 1 capital (T1 = CET 1 + AT1) |
50,695 |
63,898 |
50,717 |
Tier 2 (T2) capital before regulatory adjustments |
12,412 |
4,891 |
7,787 |
Total regulatory adjustments to Tier 2 (T2) capital |
(36) |
(496) |
(3,040) |
Tier 2 (T2) capital |
12,376 |
4,395 |
4,747 |
Total Regulatory capital (TC = T1 + T2) |
63,072 |
68,293 |
55,464 |
Total risk-weighted assets |
393,969 |
396,648 |
300,369 |
|
|
|
|
Capital ratios |
|
|
|
Common Equity Tier 1 capital ratio (as a percentage of risk-weighted assets) |
11.7 |
15.2 |
12.8 |
Tier 1 capital ratio (as a percentage of risk-weighted assets) |
12.9 |
16.1 |
16.9 |
Total Regulatory capital ratio (as a percentage of risk-weighted assets) |
16.0 |
17.2 |
18.5 |
Overview of Regulatory Capital, RWA and Capital Ratios according to pro forma CRR/CRD 4 (unaudited) |
||
|
Dec 31, 2013 |
|
in € m. |
Pro forma CRR/CRD 4 |
Pro forma CRR/CRD 4 |
Common Equity Tier 1 capital before regulatory adjustments |
53,846 |
53,557 |
Total regulatory adjustments to Common Equity Tier 1 (CET 1) capital |
(19,850) |
(1,824) |
Common Equity Tier 1 (CET 1) capital |
33,995 |
51,733 |
Additional Tier 1 (AT1) capital before regulatory adjustments |
0 |
11,741 |
Total regulatory adjustments to Additional Tier 1 (AT1) capital |
0 |
(12,785) |
Additional Tier 1 (AT1) capital |
0 |
0 |
Tier 1 capital (T1 = CET 1 + AT1) |
33,995 |
51,733 |
Tier 2 (T2) capital before regulatory adjustments |
14,291 |
6,085 |
Total regulatory adjustments to Tier 2 (T2) capital |
(107) |
(906) |
Tier 2 (T2) capital |
14,184 |
5,179 |
Total Regulatory capital (TC = T1 + T2) |
48,179 |
56,912 |
Total risk-weighted assets |
350,143 |
355,127 |
|
|
|
Capital ratios |
|
|
Common Equity Tier 1 capital ratio (as a percentage of risk-weighted assets) |
9.7 |
14.6 |
Tier 1 capital ratio (as a percentage of risk-weighted assets) |
9.7 |
14.6 |
Total Regulatory capital ratio (as a percentage of risk-weighted assets) |
13.8 |
16.0 |
Reconciliation of Consolidated Balance Sheet according to IFRS to regulatory Balance Sheet (unaudited) |
||||||||||||||||||||||||||||||||||
|
Dec 31, 2014 |
Dec 31, 2013 |
|
|||||||||||||||||||||||||||||||
in € m. |
Financial Balance Sheet |
Deconsolidation/ |
Regulatory Balance Sheet |
Financial Balance Sheet |
Deconsolidation/ |
Regulatory Balance Sheet |
References1 |
|||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
Assets: |
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Cash and due from banks |
20,055 |
(246) |
19,809 |
17,155 |
(318) |
16,836 |
|
|||||||||||||||||||||||||||
Interest-earning deposits with banks |
63,518 |
(1,358) |
62,160 |
77,984 |
(838) |
77,146 |
|
|||||||||||||||||||||||||||
Central bank funds sold and securities purchased under resale agreements |
17,796 |
0 |
17,796 |
27,363 |
0 |
27,363 |
|
|||||||||||||||||||||||||||
Securities borrowed |
25,834 |
(11) |
25,823 |
20,870 |
(15) |
20,855 |
|
|||||||||||||||||||||||||||
Financial assets at fair value through profit or loss |
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Trading assets |
195,681 |
(7,846) |
187,835 |
210,070 |
(9,921) |
200,149 |
|
|||||||||||||||||||||||||||
Positive market values from derivative financial instruments |
629,958 |
421 |
630,379 |
504,590 |
779 |
505,369 |
|
|||||||||||||||||||||||||||
Financial assets designated at fair value through profit or loss |
117,285 |
(12,490) |
104,795 |
184,597 |
(11,985) |
172,611 |
|
|||||||||||||||||||||||||||
Total financial assets at fair value through profit or loss |
942,924 |
(19,915) |
923,009 |
899,257 |
(21,128) |
878,129 |
|
|||||||||||||||||||||||||||
Financial assets available for sale |
64,297 |
434 |
64,731 |
48,326 |
(2,738) |
45,588 |
|
|||||||||||||||||||||||||||
Equity method investments |
4,143 |
(218) |
3,925 |
3,581 |
(195) |
3,386 |
h |
|||||||||||||||||||||||||||
thereof: Goodwill |
430 |
0 |
430 |
25 |
0 |
25 |
e |
|||||||||||||||||||||||||||
Loans |
405,612 |
(3,348) |
402,264 |
376,582 |
(7,413) |
369,168 |
|
|||||||||||||||||||||||||||
Property and equipment |
2,909 |
(193) |
2,716 |
4,420 |
(166) |
4,254 |
|
|||||||||||||||||||||||||||
Goodwill and other intangible assets |
14,951 |
(1,817) |
13,134 |
13,932 |
(1,943) |
11,990 |
e |
|||||||||||||||||||||||||||
Other assets |
137,980 |
(1,027) |
136,953 |
112,539 |
4,200 |
116,739 |
|
|||||||||||||||||||||||||||
thereof: Defined benefit pension fund assets |
961 |
0 |
961 |
639 |
0 |
639 |
g |
|||||||||||||||||||||||||||
Assets for current tax |
1,819 |
(115) |
1,704 |
2,322 |
(6) |
2,317 |
|
|||||||||||||||||||||||||||
Deferred tax assets |
6,865 |
(16) |
6,849 |
7,071 |
(83) |
6,987 |
f |
|||||||||||||||||||||||||||
Total assets |
1,708,703 |
(27,832) |
1,680,872 |
1,611,400 |
(30,643) |
1,580,758 |
|
|||||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Liabilities and equity: |
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Deposits |
532,931 |
4,823 |
537,754 |
527,750 |
5,167 |
532,917 |
|
|||||||||||||||||||||||||||
Central bank funds purchased and securities sold under repurchase agreements |
10,887 |
0 |
10,887 |
13,381 |
0 |
13,381 |
|
|||||||||||||||||||||||||||
Securities loaned |
2,339 |
(10) |
2,329 |
2,304 |
(12) |
2,292 |
|
|||||||||||||||||||||||||||
Financial liabilities at fair value through profit or loss |
|
|
|
|
|
|
|
|||||||||||||||||||||||||||
Trading liabilities |
41,843 |
(200) |
41,643 |
55,804 |
(219) |
55,585 |
|
|||||||||||||||||||||||||||
Negative market values from derivative financial instruments |
610,202 |
603 |
610,805 |
483,428 |
1,512 |
484,941 |
|
|||||||||||||||||||||||||||
Financial liabilities designated at fair value through profit or loss |
37,131 |
(2,315) |
34,816 |
90,104 |
(2,307) |
87,797 |
|
|||||||||||||||||||||||||||
Investment contract liabilities |
8,523 |
(8,523) |
0 |
8,067 |
(8,067) |
0 |
|
|||||||||||||||||||||||||||
Total financial liabilities at fair value through profit or loss |
697,699 |
(10,435) |
687,264 |
637,404 |
(9,081) |
628,323 |
|
|||||||||||||||||||||||||||
Other short-term borrowings |
42,931 |
(8,780) |
34,151 |
59,767 |
(11,784) |
47,983 |
|
|||||||||||||||||||||||||||
Other liabilities |
183,823 |
(12,628) |
171,195 |
163,595 |
13,639 |
149,956 |
|
|||||||||||||||||||||||||||
Provisions |
6,677 |
(81) |
6,596 |
4,524 |
(88) |
4,435 |
|
|||||||||||||||||||||||||||
Liabilities for current tax |
1,608 |
(40) |
1,568 |
1,600 |
(45) |
1,556 |
|
|||||||||||||||||||||||||||
Deferred tax liabilities |
1,175 |
(443) |
732 |
1,101 |
(331) |
769 |
|
|||||||||||||||||||||||||||
Long-term debt |
144,837 |
772 |
145,609 |
133,082 |
(1,057) |
132,025 |
|
|||||||||||||||||||||||||||
thereof: Subordinated long-term debt2 |
6,392 |
0 |
6,392 |
9,117 |
13 |
9,131 |
j, k |
|||||||||||||||||||||||||||
Trust preferred securities2 |
10,573 |
516 |
11,089 |
11,926 |
455 |
12,380 |
j, k |
|||||||||||||||||||||||||||
Obligation to purchase common shares |
0 |
0 |
0 |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||
Total liabilities |
1,635,481 |
(26,308) |
1,609,173 |
1,556,434 |
30,416 |
1,526,019 |
|
|||||||||||||||||||||||||||
Common shares, no par value, nominal value of € 2.56 |
3,531 |
0 |
3,531 |
2,610 |
0 |
2,610 |
a |
|||||||||||||||||||||||||||
Additional paid-in capital |
33,626 |
(5) |
33,621 |
26,204 |
(12) |
26,192 |
a |
|||||||||||||||||||||||||||
Retained earnings |
29,279 |
(1,107) |
28,171 |
28,376 |
(516) |
27,860 |
b |
|||||||||||||||||||||||||||
Common shares in treasury, at cost |
(8) |
0 |
(8) |
(13) |
0 |
(13) |
a |
|||||||||||||||||||||||||||
Accumulated other comprehensive income, net of tax |
1,923 |
(306) |
1,617 |
(2,457) |
418 |
(2,039) |
c |
|||||||||||||||||||||||||||
Total shareholders’ equity |
68,351 |
(1,419) |
66,932 |
54,719 |
(110) |
54,609 |
|
|||||||||||||||||||||||||||
Additional equity components |
4,619 |
0 |
4,619 |
0 |
0 |
0 |
i |
|||||||||||||||||||||||||||
Noncontrolling interests |
253 |
(105) |
148 |
247 |
(117) |
130 |
d |
|||||||||||||||||||||||||||
Total equity |
73,223 |
(1,523) |
71,699 |
54,966 |
(227) |
54,739 |
|
|||||||||||||||||||||||||||
Total liabilities and equity |
1,708,703 |
(27,832) |
1,680,872 |
1,611,400 |
(30,643) |
1,580,758 |
|
Transitional template for Regulatory Capital, RWA and Capital Ratios according to CRR/CRD 4 (unaudited) and Basel 2.5 (audited) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Dec 31, 2014 |
Dec 31, 2013 |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
in € m. |
CRR/CRD 4 |
CRR/CRD 4 |
Basel 2.5 |
References1 |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Equity Tier 1 (CET 1) capital: instruments and reserves |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capital instruments and the related share premium accounts |
37,144 |
37,144 |
28,789 |
a |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: Ordinary shares2 |
37,144 |
37,144 |
28,789 |
a |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Retained earnings |
26,509 |
26,509 |
27,195 |
b |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accumulated other comprehensive income (loss), net of tax |
1,617 |
1,923 |
(2,457) |
c |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Funds for general banking risk |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount of qualifying items referred to in Art. 484 (3) CRR and the related share premium accounts subject to phase-out from CET 1 |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Public sector capital injections grandfathered until January 1, 2018 |
N/M |
N/M |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Noncontrolling Interests (amount allowed in consolidated CET 1) |
0 |
118 |
130 |
d |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Independently reviewed interim profits net of any foreseeable charge or dividend3 |
481 |
481 |
(98) |
b |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Equity Tier 1 (CET 1) capital before regulatory adjustments |
65,750 |
66,175 |
53,558 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Equity Tier 1 (CET 1) capital: regulatory adjustments |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional value adjustments (negative amount)4 |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intangible assets (net of related tax liabilities) (negative amount) |
(12,979) |
(2,596) |
(11,466) |
e |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred tax assets that rely on future profitability excluding those arising from temporary differences (net of related tax liabilities where the conditions in Art. 38 (3) CRR are met) (negative amount) |
(2,620) |
(524) |
N/M |
f |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair value reserves related to gains or losses on cash flow hedges |
(181) |
(181) |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shortfall of provisions to expected losses (negative amount) |
(712) |
(147) |
(430) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Any increase in equity that results from securitized assets (negative amount) |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gains or losses on liabilities designated at fair value resulting from changes in own credit standing5 |
(544) |
(210) |
(1) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Defined benefit pension fund assets (negative amount) |
(961) |
(192) |
N/M |
g |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings by an institution of own CET 1 instruments (negative amount)6 |
(54) |
(11) |
(3) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings of the CET 1 instruments of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution (negative amount) |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings by the institution of the CET 1 instruments of financial sector entities where the institution does not have a significant investment in those entities (amount above the 10 % threshold and net of eligible short positions) (negative amount)7 |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings by the institution of the CET 1 instruments of financial sector entities where the institution has a significant investment in those entities (amount above 10 % threshold and net of eligible short positions) (negative amount)8 |
0 |
0 |
(1,589) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Exposure amount of the following items which qualify for a Risk Weight of 1250 %, where the institution opts for the deduction alternative |
0 |
0 |
(945) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Qualifying holdings outside the financial sector (negative amount) |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Securitization positions (negative amount) |
0 |
0 |
(945) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Free deliveries (negative amount) |
0 |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred tax assets arising from temporary differences (amount above 10 % threshold, net of related tax liabilities where the conditions in Art. 38 (3) CRR are met) (negative amount) |
(78) |
(16) |
N/M |
f |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount exceeding the 15 % threshold (negative amount) |
(1,199) |
(202) |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings by the institution of the CET 1 instruments of financial sector entities where the institution has a significant investment in those entities |
(499) |
(84) |
N/M |
h |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred tax assets arising from temporary differences |
(700) |
(118) |
N/M |
f |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Losses for the current financial year (negative amount) |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regulatory adjustments applied to CET 1 capital in respect of amounts subject to pre-CRR treatment: |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regulatory adjustments relating to unrealized gains and losses pursuant to Art. 467 and 468 CRR9 |
N/M |
(1,648) |
(215) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount to be deducted from or added to CET 1 capital with regard to additional filters and deductions required pre CRR10 |
(345) |
(345) |
(374) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Qualifying AT1 deductions that exceed the AT1 capital of the institution (negative amount) |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Other regulatory adjustments |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total regulatory adjustments to Common Equity Tier 1 (CET 1) capital |
(19,674) |
(6,072) |
(15,024) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Equity Tier 1 (CET 1) capital |
46,076 |
60,103 |
38,534 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Tier 1 (AT1) capital: instruments |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capital instruments and the related share premium accounts |
4,676 |
4,676 |
12,701 |
i |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Classified as equity under applicable accounting standards |
4,676 |
4,676 |
0 |
i |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Classified as liabilities under applicable accounting standards |
0 |
0 |
12,701 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount of qualifying items referred to in Art. 484 (4) CRR and the related share premium accounts subject to phase-out from AT1 |
N/M |
10,021 |
N/M |
j |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Public sector capital injections grandfathered until January 1, 2018 |
N/M |
N/M |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Qualifying Tier 1 capital included in consolidated AT1 capital issued by subsidiaries and held by third parties |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: instruments issued by subsidiaries subject to phase-out |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Tier 1 (AT1) capital before regulatory adjustments |
4,676 |
14,696 |
12,701 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Tier 1 (AT1) capital: regulatory adjustments |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings by an institution of own AT1 instruments (negative amount)11 |
(57) |
(57) |
(519) |
i |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings of the AT1 instruments of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution (negative amount) |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings of the AT1 instruments of financial sector entities where the institution does not have a significant investment in those entities (amount above the 10 % threshold and net of eligible short positions) (negative amount)7 |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings by the institution of the AT1 instruments of financial sector entities where the institution has a significant investment in those entities (amount above the 10 % threshold net of eligible short positions) (negative amount)8 |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regulatory adjustments applied to AT1 capital in respect of amounts subject to pre-CRR treatment and transitional treatments subject to phase-out as prescribed in CRR (i.e., residual amounts) |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Residual amounts deducted from AT1 capital with regard to deduction from CET 1 capital during the transitional period pursuant to Art. 472 CRR |
N/M |
(10,845) |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Intangible assets (net of related tax liabilities) |
N/M |
(10,383) |
N/M |
e |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shortfall of provisions to expected losses |
N/M |
(294) |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings by the institution of the CET 1 instruments of financial sector entities where the institution has a significant investment in those entities |
N/M |
(168) |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Residual amounts deducted from AT1 capital with regard to deduction from Tier 2 (T2) capital during the transitional period pursuant to Art. 475 CRR |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount to be deducted from or added to AT1 capital with regard to additional filters and deductions required pre CRR |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Qualifying T2 deductions that exceed the T2 capital of the institution (negative amount) |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total regulatory adjustments to Additional Tier 1 (AT1) capital12 |
(57) |
(10,902) |
(519) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Additional Tier 1 (AT1) capital |
4,619 |
3,794 |
12,182 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tier 1 capital (T1 = CET 1 + AT1)13 |
50,695 |
63,898 |
50,717 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tier 2 (T2) capital: instruments and provisions |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capital instruments and the related share premium accounts14 |
11,505 |
2,942 |
7,787 |
k |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount of qualifying items referred to in Art. 484 (5) CRR and the related share premium accounts subject to phase-out from T2 |
N/M |
721 |
N/M |
k |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Public sector capital injections grandfathered until January 1, 2018 |
N/M |
N/M |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Qualifying own funds instruments included in consolidated T2 capital issued by subsidiaries and held by third parties |
908 |
1,228 |
0 |
k |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: instruments issued by subsidiaries subject to phase-out |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Credit risk adjustments |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tier 2 (T2) capital before regulatory adjustments |
12,412 |
4,891 |
7,787 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tier 2 (T2) capital: regulatory adjustments |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings by an institution of own T2 instruments and subordinated loans (negative amount)11 |
(36) |
(34) |
(75) |
k |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings of the T2 instruments and subordinated loans of financial sector entities where those entities have reciprocal cross holdings with the institution designed to inflate artificially the own funds of the institution (negative amount) |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings of the T2 instruments and subordinated loans of financial sector entities where the institution does not have a significant investment in those entities (amount above 10 % threshold and net of eligible short positions) (negative amount)7 |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
New holdings not subject to transitional arrangements |
N/M |
N/M |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Holdings existing before January 1, 2013 and subject to transitional arrangements |
N/M |
N/M |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings by the institution of the T2 instruments and subordinated loans of financial sector entities where the institution has a significant investment in those entities (net of eligible short positions) (negative amount)8 |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Regulatory adjustments applied to Tier 2 in respect of amounts subject to pre-CRR treatment and transitional treatments subject to phase-out as prescribed in CRR (i.e., residual amounts) |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Residual amounts deducted from Tier 2 capital with regard to deduction from Common Equity Tier 1 capital during the transitional period pursuant to Art. 472 CRR |
N/M |
(462) |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Shortfall of provisions to expected losses |
N/M |
(294) |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings by the institution of the CET 1 instruments of financial sector entities where the institution has a significant investment in those entities |
N/M |
(168) |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Residual amounts deducted from Tier 2 capital with regard to deduction from Additional Tier 1 capital during the transitional period pursuant to Art. 475 CRR |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Reciprocal cross holdings in AT1 instruments |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct holdings of nonsignificant investments in the capital of other financial sector entities |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount to be deducted from or added to Tier 2 capital with regard to additional filters and deductions required pre-CRR |
0 |
0 |
(2,965) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total regulatory adjustments to Tier 2 (T2) capital |
(36) |
(496) |
(3,040) |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tier 2 (T2) capital |
12,376 |
4,395 |
4,747 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Regulatory capital (TC = T1 + T2) |
63,072 |
68,293 |
55,464 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Risk-weighted assets in respect of amounts subject to pre-CRR treatment and transitional treatments subject to phase-out as prescribed in CRR (i.e., residual amounts)15 |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Items not deducted from CET 1 (CRR residual amounts) |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Items not deducted from AT1 items (CRR residual amounts) |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Items not deducted from T2 items (CRR residual amounts) |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Indirect and synthetic holdings of own T2 instruments |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Indirect and synthetic holdings of nonsignificant investments in the capital of other financial sector entities |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Indirect and synthetic holdings of significant investments in the capital of other financial sector entities |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total risk-weighted assets |
393,969 |
396,648 |
300,369 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Credit Risk (including Settlement Risk) |
241,475 |
244,155 |
202,219 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Credit Valuation Adjustment (CVA) |
21,203 |
21,203 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Risk |
64,209 |
64,209 |
47,259 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Operational Risk |
67,082 |
67,082 |
50,891 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capital ratios and buffers |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Equity Tier 1 capital ratio (as a percentage of risk-weighted assets) |
11.7 |
15.2 |
12.8 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tier 1 capital ratio (as a percentage of risk-weighted assets) |
12.9 |
16.1 |
16.9 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Total Regulatory capital ratio (as a percentage of risk-weighted assets) |
16.0 |
17.2 |
18.5 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Institution specific buffer requirement (CET 1 requirement in accordance with Art. 92 (1) (a) CRR plus capital conservation and countercyclical buffer requirements, plus systemic risk buffer, plus the systemically important institution buffer (G-SII or O-SII buffer), expressed as a percentage of risk-weighted assets)16 |
9.0 |
4.0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Thereof: |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capital conservation buffer requirement |
2.5 |
0.0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Countercyclical buffer requirement17 |
N/M |
N/M |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Systemic risk buffer requirement |
0.0 |
0.0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Global Systemically Important Institution (G-SII) or Other Systemically Important Institution (O-SII) buffer18 |
2.0 |
0.0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Common Equity Tier 1 capital available to meet buffers (as a percentage of risk-weighted assets)19 |
6.9 |
9.2 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amounts below the thresholds for deduction (before risk weighting) |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings of the capital of financial sector entities where the institution does not have a significant investment in those entities (amount below 10 % threshold and net of eligible short positions)7 |
3,148 |
3,148 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Direct, indirect and synthetic holdings by the institution of the CET 1 instruments of financial sector entities where the institution has a significant investment in those entities (amount below 10 % threshold and net of eligible short positions)8 |
2,877 |
2,956 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Deferred tax assets arising from temporary differences (amount below 10 % threshold, net of related tax liability where the conditions in Art. 38 (3) CRR are met) |
4,035 |
4,146 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Applicable caps on the inclusion of provisions in Tier 2 capital |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Credit risk adjustments included in T2 in respect of exposures subject to standardized approach (prior to the application of the cap) |
0 |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cap on inclusion of credit risk adjustments in T2 under standardized approach |
454 |
454 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Credit risk adjustments included in T2 in respect of exposures subject to internal ratings-based approach (prior to the application of the cap) |
0 |
0 |
0 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cap for inclusion of credit risk adjustments in T2 under internal ratings-based approach |
991 |
991 |
894 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Capital instruments subject to phase-out arrangements |
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Current cap on CET 1 instruments subject to phase-out arrangements |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount excluded from CET 1 due to cap (excess over cap after redemptions and maturities) |
N/M |
0 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Current cap on AT1 instruments subject to phase-out arrangements |
N/M |
10,021 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount excluded from AT1 due to cap (excess over cap after redemptions and maturities) |
N/M |
446 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Current cap on T2 instruments subject to phase-out arrangements |
N/M |
2,701 |
N/M |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Amount excluded from T2 due to cap (excess over cap after redemptions and maturities) |
N/M |
0 |
N/M |
|
The following table details the main changes in our Common Equity Tier 1 capital, Additional Tier 1 and Tier 2 capital, based on the regulatory eligible amounts, from the beginning to the end of the years 2014 and 2013.
Development of regulatory capital |
||||||
|
Dec 31, 2014 |
Dec 31, 2013 |
||||
in € m. |
CRR/CRD 4 |
Basel 2.5 |
||||
|
||||||
Common Equity Tier 1 (CET 1) capital - opening amount1 |
38,534 |
37,957 |
||||
Common shares, net effect |
921 |
230 |
||||
thereof: |
|
|
||||
New shares issued (+) |
921 |
230 |
||||
Shares retired (–) |
0 |
0 |
||||
Additional paid-in capital |
7,429 |
2,428 |
||||
Retained earnings |
1,077 |
(57) |
||||
thereof: |
|
|
||||
Actuarial gains (losses) rel. to defined benefit plans, net of tax/CTA |
5 |
(659) |
||||
Net income attributable to Deutsche Bank Shareholders |
1,663 |
666 |
||||
Common shares in treasury, net effect/(+) sales (–) purchase |
6 |
47 |
||||
Movements in accumulated other comprehensive income |
2,947 |
(1,121) |
||||
thereof: |
|
|
||||
Foreign currency translation, net of tax |
2,865 |
(1,121) |
||||
Unrealized gains and losses |
0 |
0 |
||||
Other |
82 |
0 |
||||
Accrual for dividend and AT1 coupons |
(1,182) |
(765) |
||||
thereof: |
|
|
||||
Gross dividends (deduction) |
(1,034) |
(765) |
||||
Shares issued in lieu of dividends (add back) |
0 |
0 |
||||
Gross AT1 coupons (deduction) |
(148) |
0 |
||||
Additional valuation adjustments |
0 |
0 |
||||
Intangible assets (net of related tax liabilities) |
8,870 |
113 |
||||
therein: first day effect of application of CRR/CRD 4 rules |
9,173 |
N/M |
||||
Deferred tax assets that rely on future profitability (excluding those arising from temporary differences) |
(524) |
0 |
||||
therein: first day effect of application of CRR/CRD 4 rules |
(441) |
N/M |
||||
Excess of expected losses over risk provisions |
283 |
9 |
||||
therein: first day effect of application of CRR/CRD 4 rules |
231 |
N/M |
||||
Removal of gains/losses resulting from changes in own credit standing in liabilities designated at fair value (net of tax) |
(209) |
1 |
||||
therein: first day effect of application of CRR/CRD 4 rules |
(103) |
N/M |
||||
Defined benefit pension fund assets |
(192) |
N/M |
||||
therein: first day effect of application of CRR/CRD 4 rules |
(133) |
N/M |
||||
Direct, indirect and synthetic holdings by the institution of the CET1 instruments of financial sector entities where the institution has a significant investment in those entities |
1,505 |
(96) |
||||
therein: first day effect of application of CRR/CRD 4 rules |
1,469 |
N/M |
||||
Securitization positions not included in risk-weighted assets |
945 |
7 |
||||
therein: first day effect of application of CRR/CRD 4 rules |
945 |
N/M |
||||
Deferred tax assets arising from temporary differences (amount above 10 % and 15 % threshold, net of related tax liabilities where the conditions in Art. 38 (3) CRR are met) |
(133) |
0 |
||||
therein: first day effect of application of CRR/CRD 4 rules |
(474) |
N/M |
||||
Other, including regulatory adjustments |
(174) |
(218) |
||||
therein: first day effect of application of CRR/CRD 4 rules |
(226) |
N/M |
||||
Common Equity Tier 1 (CET 1) capital – closing amount |
60,103 |
38,534 |
||||
|
|
|
||||
Additional Tier 1 (AT1) capital – opening amount1 |
12,182 |
12,526 |
||||
New Additional Tier 1 eligible capital issues |
4,619 |
0 |
||||
Matured and called instruments |
(2,512) |
0 |
||||
Transitional arrangements |
(11,292) |
N/M |
||||
thereof: |
|
|
||||
Amount excluded from Additional Tier 1 due to cap |
(446) |
N/M |
||||
Intangible assets (net of related tax liabilities) |
(10,383) |
N/M |
||||
Shortfall of provisions to expected losses |
(294) |
N/M |
||||
Direct, indirect and synthetic holdings by the institution of the CET 1 instruments of financial sector entities where the institution has a significant investment in those entities |
(168) |
N/M |
||||
therein: first day effect of application of CRR/CRD 4 rules |
(11,972) |
N/M |
||||
Other, including regulatory adjustments |
797 |
(344) |
||||
Additional Tier 1 (AT1) capital - closing amount |
3,794 |
12,182 |
||||
Tier 1 capital (T1 = CET 1 + AT1) |
63,898 |
50,717 |
||||
|
|
|
||||
Tier 2 (T2) capital - opening amount1 |
4,747 |
6,532 |
||||
New Tier 2 eligible capital issues |
83 |
1,088 |
||||
Matured and called instruments |
(1,615) |
(965) |
||||
Amortization adjustments |
(1,502) |
(1,871) |
||||
Transitional arrangements |
2,949 |
N/M |
||||
thereof: |
|
|
||||
Inclusion of amount excluded from Additional Tier 1 due to cap |
446 |
N/M |
||||
Amount to be deducted from or added to Additional Tier 2 capital with regard to additional filters and deductions required pre-CRR |
2,965 |
N/M |
||||
Shortfall of provisions to expected losses |
(294) |
N/M |
||||
Direct, indirect and synthetic holdings by the institution of the CET 1 instruments of financial sector entities where the institution has a significant investment in those entities |
(168) |
N/M |
||||
Other, including regulatory adjustments |
(268) |
(37) |
||||
Tier 2 (T2) capital - closing amount |
4,395 |
4,747 |
||||
Total Regulatory capital (TC = T1 + T2) |
68,293 |
55,464 |
Reconciliation of shareholders’ equity to regulatory capital |
||||||
|
Dec 31, 2014 |
Dec 31, 2013 |
||||
in € m. |
CRR/CRD 4 |
Basel 2.5 |
||||
|
||||||
Total shareholders’ equity per accounting balance sheet |
68,351 |
54,719 |
||||
Deconsolidation/Consolidation of entities |
(1,419) |
(110) |
||||
thereof: |
|
|
||||
Additional paid-in capital |
(5) |
(12) |
||||
Retained Earnings |
(1,107) |
(516) |
||||
Accumulated other comprehensive income, net of tax |
(306) |
418 |
||||
Total shareholders' equity per regulatory balance sheet |
66,932 |
54,609 |
||||
Noncontrolling interests based on transitional rules |
118 |
130 |
||||
Accrual for dividend and AT1 coupons |
(1,182) |
(765) |
||||
Reversal of deconsolidation/consolidation of accumulated other comprehensive income, net of tax, during transitional period |
306 |
(418) |
||||
Common Equity Tier 1 capital before regulatory adjustments |
66,175 |
53,556 |
||||
Prudential filters |
(2,039) |
(216) |
||||
thereof: |
|
|
||||
Additional value adjustments |
0 |
0 |
||||
Any increase in equity that results from securitized assets |
0 |
0 |
||||
Fair value reserves related to gains or losses on cash flow hedges and gains or losses on liabilities designated at fair value resulting from changes in own credit standing |
(391) |
(1) |
||||
Regulatory adjustments relating to unrealized gains and losses pursuant to Art. 467 and 468 CRR |
(1,648) |
(215) |
||||
Regulatory adjustments |
(4,032) |
(14,807) |
||||
thereof: |
|
|
||||
Intangible assets (net of related tax liabilities) |
(2,596) |
(11,466) |
||||
Deferred tax assets that rely on future profitability |
(657) |
N/M |
||||
Shortfall of provisions to expected loss |
(147) |
(430) |
||||
Defined benefit pension fund assets |
(192) |
N/M |
||||
Direct, indirect and synthetic holdings by the institution of the CET 1 instruments of financial sector entities where the institution has a significant investment in those entities |
(84) |
(1,589) |
||||
Securitization positions not included in risk-weighted assets |
0 |
(945) |
||||
Other1 |
(356) |
(377) |
||||
Common Equity Tier 1 capital |
60,103 |
38,534 |
||||
|
|
|
||||
Additional Tier 1 capital |
3,794 |
12,182 |
||||
Additional Tier 1 Notes (AT1 Notes) |
4,619 |
0 |
||||
Per balance sheet |
4,619 |
0 |
||||
Deconsolidation/Consolidation of entities |
0 |
0 |
||||
Regulatory adjustments to balance sheet position |
0 |
0 |
||||
Hybrid capital securities |
10,002 |
12,163 |
||||
Per balance sheet |
10,573 |
11,926 |
||||
Deconsolidation/Consolidation of entities |
516 |
455 |
||||
Regulatory adjustments to balance sheet position |
(1,087) |
(218) |
||||
thereof: |
|
|
||||
Amount excluded from Additional Tier 1 due to cap |
(446) |
N/M |
||||
Other |
(640) |
(218) |
||||
Other regulatory adjustments |
19 |
20 |
||||
Deductions from Additional Tier 1 capital |
(10,845) |
0 |
||||
|
|
|
||||
Tier 1 capital |
63,898 |
50,717 |
||||
|
|
|
||||
Tier 2 capital |
4,395 |
4,747 |
||||
Subordinated debt |
4,120 |
7,293 |
||||
Per balance sheet |
6,392 |
9,117 |
||||
Deconsolidation/Consolidation of entities |
0 |
13 |
||||
Regulatory adjustments to balance sheet position |
(2,272) |
(1,837) |
||||
thereof: |
|
|
||||
Amortization according to Art. 64 CRR |
(2,101) |
(2,109) |
||||
Other |
(171) |
272 |
||||
Other regulatory adjustments |
737 |
419 |
||||
thereof: |
|
|
||||
Inclusion of amount excluded from Additional Tier 1 due to cap |
446 |
N/M |
||||
Other |
291 |
419 |
||||
Deductions from Tier 2 capital |
(462) |
(2,965) |
||||
|
|
|
||||
Total Regulatory capital |
68,293 |
55,464 |